Birth weight variation is influenced by fetal and maternal genetic and non-genetic factors, and has been reproducibly associated with future cardio-metabolic health outcomes. In expanded genome-wide association analyses of own birth weight (n = 321,223) and offspring birth weight (n = 230,069 mothers), we identified 190 independent association signals (129 of which are novel). We used structural equation modeling to decompose the contributions of direct fetal and indirect maternal genetic effects, then applied Mendelian randomization to illuminate causal pathways. For example, both indirect maternal and direct fetal genetic effects drive the observational relationship between lower birth weight and higher later blood pressure: maternal blood pressure-raising alleles reduce offspring birth weight, but only direct fetal effects of these alleles, once inherited, increase later offspring blood pressure. Using maternal birth weight-lowering genotypes to proxy for an adverse intrauterine environment provided no evidence that it causally raises offspring blood pressure, indicating that the inverse birth weight-blood pressure association is attributable to genetic effects, and not to intrauterine programming.
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors

B
irth weight is an important predictor of newborn and infant survival, is a key indicator of pregnancy outcomes, and is observationally associated with future risk of adult cardiometabolic diseases in offspring. These observational associations are often assumed to reflect adaptations made by a developing fetus in response to an adverse intrauterine environment-a concept termed the developmental origins of health and disease (DOHaD) 1 . Support for DOHaD is primarily from animal models (reviewed in ref. 2 ). Observational studies of famine-exposed populations support prenatal programming in relation to type 2 diabetes (T2D), but not other cardio-metabolic health measures (reviewed in ref. 3 ). However, DOHaD cannot provide a complete explanation for the relationship between lower birth weight and increased risk of cardio-metabolic disease. Other probable contributing factors are (1) environmental confounding, leading to phenotypic associations across the life-course 4 and (2) shared genetic effects operating at the population level 5 . Genetic associations between birth weight and later cardio-metabolic diseases may arise from the direct effects of the same inherited genetic variants at different stages of the life-course 6 . However, consideration of an individual's own genotype in isolation cannot exclude potential confounding by any indirect effects of the correlated maternal genotype (r = ~0.5) on the intrauterine, and possibly postnatal, environment. Evidence for indirect maternal effects on birth weight and later offspring disease risk could implicate the intrauterine environment in later-life disease etiology.
To date, 65 genetic loci have been associated with birth weight in genome-wide association studies (GWASs), implicating biological pathways that may underlie observational associations with adult disease 5, [7] [8] [9] . However, most of these studies did not distinguish between maternal and fetal genetic influences. Evidence from monogenic human models 10 and variance component analyses 11 demonstrates that birth weight is influenced by genotypes inherited by the fetus and by maternal genotypes that influence the intrauterine environment. To date, GWASs of own birth weight 5 and maternal GWASs of offspring birth weight 7 have produced overlapping signals due to the correlation between maternal and fetal genotypes. Identified birth weight variants might have (1) a direct fetal effect only; (2) an indirect maternal effect only; or (3) some combination of the two. Performing separate GWAS analyses of own or offspring birth weight precludes full resolution of the origin of the identified genetic effects.
To address these issues, we performed greatly expanded GWASs of own (n = 321,223) and offspring birth weight (n = 230,069 mothers) using data from the Early Growth Genetics (EGG) Consortium and the UK Biobank (2017 release). We applied a structural equation model that we recently developed to partition genetic effects on birth weight into maternal and fetal components at genomewide-significant loci 7, 12 . We then extended the method to estimate maternal-and fetal-specific genetic effects across the genome in a computationally efficient manner, and used the results for downstream analyses. Our ability to resolve maternal and fetal genetic contributions provides substantial insights into the underlying biological regulation of birth weight, as well as the origins of observational relationships with T2D and blood pressure.
the same lead SNP and 21 loci had correlated fetal and maternal lead SNPs (r 2 ≥ 0.1). Colocalization analysis indicated that 19/21 of these correlated lead SNP pairs were probably tagging the same birth weight signal (posterior probability > 0.5). Therefore, we identified a total of 190 independent association signals, represented by 209 lead SNPs ( Supplementary Fig. 4 and Supplementary Table 5a ). Of the 209 lead SNPs, 146 are novel (representing 129 independent association signals), 3 are rare (minor allele frequency (MAF) < 1%) and 13 are low frequency (1% ≤ MAF < 5%). The three rare variants (at the YKT6/GCK, ACVR1C and MIR146B loci) alter birth weight by more than double the effect (>100 g per allele) of the first common variants identified 9 . In the independent Norwegian Mother and Child Cohort Study (MoBa-HARVEST; n = 13,934 mother-offspring duos), the lead SNPs explained 7% of the variance in birth weight, calculated as the sum of variances explained by the fetal genotype (6%) and maternal genotype (2%), plus twice the covariance (−0.5%). Maternal genome-wide complex trait analysis (M-GCTA 11 ), which estimates SNP heritability, and partitions this quantity into maternal and fetal components, estimated that 39.8% of the variance in birth weight could be explained by tagged fetal genetic variation (28.5%), tagged maternal genetic variation (7.6%) and twice the covariance (3.7%).
We integrated data from several sources to highlight possible causal genes underlying the identified associations, including gene-level expression data across 43 tissues (from GTEx version 6p 14 ), placental expression quantitative trait loci (eQTL) 15 , topologically associating domains (TADs) identified in human embryonic stem cells 16, 17 and non-synonymous SNPs (see Supplementary  Table 5a ,b and Methods). Several genes were highlighted by multiple approaches; however, further functional studies are required to confirm causality.
Structural equation model to estimate maternal and fetal effects.
Next, we partitioned the 209 lead SNPs into 5 categories based on their maternal and/or fetal genetic contributions to birth weight. To achieve this, we used structural equation modeling (SEM), which accounts for the correlation between fetal and maternal genotypes and thereby provides unbiased estimates of the maternal and fetal genetic effects on birth weight 12 Table 5 . Using the confidence intervals (CIs) around the SEM-adjusted maternal and fetal effect estimates, we identified 64 SNPs with fetal-only effects, 32 SNPs with maternal-only effects, 27 SNPs with directionally concordant fetal and maternal effects and 15 SNPs with directionally opposing fetal and maternal effects ( Supplementary  Fig. 8 ). For example, rs10830963 at MTNR1B was identified in both the own-birth-weight (P = 2.8 × 10 −11 ) and offspring-birth-weight GWAS (P = 9.1 × 10 −39 ), but the SEM analysis revealed that its effect was exclusively maternal (P SEMfetal = 0.7; P SEMmaternal = 4.6 × 10 −19 ). In contrast, rs560887 at G6PC2 was identified only in the GWAS of offspring birth weight (P = 1.2 × 10 −14 ), but was found to have directionally opposing maternal and fetal effects (β SEMfetal = −0.03; P SEMfetal = 2.8 × 10 −8 ; β SEMmaternal = 0.04; P SEMmaternal = 5.4 × 10 −14 ). At present, these categories are suggestive, as the current sample size has insufficient statistical power to detect small genetic effects, particularly maternal effects. Some SNPs that were classified as fetal only may have had a small undetected maternal effect. In addition, 71 SNPs remained unclassified. Asymptotic power calculations showed that we had 80% power to detect fetal (maternal) effects that explained 0.006% (0.008%) of the variance in birth weight (α = 0.05). However, there was strong consistency with traditional conditional linear regression modeling in n = 18,873 mother-offspring pairs (Supplementary Table 6 and Methods), and overall, the method gave a clear indication as to which genetic associations are driven by the maternal or fetal genomes.
To extend the estimates of adjusted maternal and fetal effects genome wide, we developed a weighted linear model (WLM) (see Methods), which yields a good approximation to the SEM with equivalent estimates for the 209 lead SNPs (Supplementary Fig. 9 ). This was necessary because the SEM is too computationally intensive to fit across the genome. The adjusted fetal and maternal genotype effect estimates on birth weight from the WLM are hereafter referred to as WLM-adjusted estimates. Using linkage disequilibrium score regression 18 , we observed that the genetic correlation between the WLM-adjusted maternal and fetal effects (r g = 0.10; P = 0.12) was substantially lower than that between the unadjusted effects from the original GWAS (r g = 0.82; P < 0.01), indicating that the WLM largely accounts for the underlying correlation between fetal and maternal genotypes. No additional novel loci were identified, but we used the WLM-adjusted estimates in downstream analyses to identify fetal-and maternal-specific mechanisms that regulate birth weight, and to investigate the genetic links between birth weight and adult traits.
Maternal-and fetal-specific tissues and mechanisms underlying birth weight regulation. Tests of global enrichment of birth weight SNP associations across tissues sampled from the GTEx project 14 using LD-SEG 19 are presented in Supplementary Fig. 10 . Only enrichment for maternal-specific SNP associations for genes expressed in connective/bone tissues was detected after Bonferroni correction. Integration of epigenetic signatures defined by the Roadmap Epigenomics Project highlighted a significant enrichment of maternal-specific effects in the ovary for histone modification marks (H3K4me1) and regions of open chromatin (Supplementary Table 7 ); no significant enrichment was detected for other signatures. Gene set enrichment analysis implicated different fetal- (Supplementary Table 8 ) and maternal-specific (Supplementary Table 9 ) gene sets.
A major determinant of birth weight is the duration of gestation. Using linkage disequilibrium score regression 18 , we found a substantial genetic correlation between published maternal genetic effects on gestational duration 20 and the WLM-adjusted maternal effects on offspring birth weight (r g = 0.63; P = 2.1 × 10 −5 ; Supplementary  Table 10 and Methods), but not with the WLM-adjusted fetal effects on own birth weight (r g = −0.10; P = 0.34). Gestational duration was unavailable for >85% of individuals in the birth weight GWAS analyses, so it is possible that some identified association signals influence birth weight primarily by altering gestational duration. We looked up the 209 lead birth-weight-associated SNPs in the published maternal GWAS of gestational duration 20 (Supplementary  Table 11 ) and followed up 7 associated SNPs (P < 2.4 × 10
, corrected for 209 tests; Methods) in 13,206 mother-child pairs. Meta-analysis with summary data from 23andMe 20 strengthened associations with gestational duration at five of seven loci (EBF1, AGTR2, ZBTB38, KCNAB1 and KLHL25/AKAP13; Supplementary Table 12 ). The precise causal relationship between fetal growth and gestational duration at these loci requires further investigation; however, the majority of associations with birth weight do not appear to be driven by associations with gestational duration.
Maternal-and fetal-specific genetic correlations between birth weight and adult traits. The 209 lead birth-weight-associated SNPs were associated with other phenotypes in previously published GWASs and the UK Biobank (Supplementary Table 13 and Methods). At the genome-wide level, we previously reported genetic correlations between own birth weight and several adult cardiometabolic traits 5 , but were unable to distinguish the direct fetal genotype contribution from the indirect contribution of maternal genotype. To understand these distinct contributions, we calculated genetic correlations using linkage disequilibrium score regression 18 between WLM-adjusted fetal and maternal SNP effect estimates and GWAS estimates for a range of traits (Fig. 2, Supplementary  Table 10 and Methods). For many traits (for example, adult height), the fetal-specific genetic correlation was similar to the maternalspecific genetic correlation, but for some traits, the fetal-and maternal-specific genetic correlations were different in magnitude (for example, systolic blood pressure (SBP)) or even in direction (for example, T2D). For several glycemic traits (for example, fasting glucose), the genetic correlations estimated using the WLM-adjusted effects were substantially different from those estimated using the unadjusted effects, showing the importance of accounting for the maternal-fetal genotype correlation.
Using genetics to estimate causal effects of intrauterine exposures on birth weight. The separation of direct fetal genotype effects from indirect maternal genotype effects on birth weight offers the novel opportunity to estimate unconfounded causal influences of intrauterine exposures by using Mendelian randomization analyses. The principle of Mendelian randomization is similar to that of a randomized controlled trial: parental alleles are randomly transmitted to offspring and are therefore generally free from confounding 21, 22 . Consequently, an association between a maternal genetic variant for an exposure of interest, and offspring birth weight, after accounting for fetal genotype, provides evidence that the maternal exposure is causally related to offspring birth weight (Fig. 3a) . Previous attempts to estimate causal effects of maternal exposures on offspring birth weight were limited by an inability to adjust for fetal genotype in adequately powered samples 23 , which can now be overcome by using WLM-adjusted estimates. We applied two-sample Mendelian randomization 24 to estimate causal effects of maternal exposures on offspring birth weight, focusing on height, glycemic traits and blood pressure. We selected SNPs known to be associated with each exposure, and regressed the WLM-adjusted maternal effects on birth weight for those SNPs against the effect estimates for the maternal exposure, weighting by the inverse of the variance of the maternal exposure effect estimates. In the same way, we used the WLM-adjusted fetal effects to estimate the casual effect of the offspring's genetic potential on their own birth weight, and compared the results with the estimated maternal causal effects.
Height and birth weight. Classical animal experiments 25 showed that larger maternal size can support greater fetal growth. This is supported by observational human data showing that offspring height shifts from being closer to the maternal than the paternal height percentile in infancy towards mid-parental height in adulthood, the latter reflecting the predominant role of inherited genetic variation 26 . However, several observational studies have provided mixed evidence regarding correlations between maternal or paternal height and offspring birth weight. Some studies show a stronger correlation with maternal than paternal height 27, 28 , which would be consistent with a role for intrauterine effects, while others show that maternal and paternal height are both strongly correlated with offspring birth weight [29] [30] [31] . The Mendelian randomization analysis, using 693 height-associated SNPs 32 (Supplementary Table 14) , estimated that a 1 s.d. (6 cm) higher maternal height is causally associated with a 0.11 s.d. (95% CI: 0.10 to 0.13) higher offspring birth weight (Fig. 3b) , independent of the direct fetal effects. A similar estimate was obtained using the WLM-adjusted fetal effects on own birth weight (0.11 s.d. (95% CI: 0.09 to 0.13)), reflecting the role of inherited height alleles (Supplementary Table 15 ). Both a previous study 33 and complementary analysis using transmitted and nontransmitted height alleles in mother-offspring pairs estimated a much larger contribution of direct fetal effects than indirect maternal effects to offspring birth weight (Supplementary Table 16 and Methods), but with relatively small sample sizes. In contrast with a previous report 33 , there was little supportive evidence that the maternal height effect on birth weight was via prolonged gestation (P = 0.12; Supplementary Table 15). These Mendelian randomization results are consistent with the hypothesis that greater maternal height causally increases birth weight, and that this effect is independent of the direct birth weight-raising effect of height alleles The color of each point indicates the SEM-adjusted fetal effect on the own-birth-weight association P value and the shape of each point indicates the SEM-adjusted maternal effect on the offspring-birth-weight association P value. P values for the fetal and maternal effect were calculated using a two-sided Wald test. SNPs labeled with the name of the closest gene are those that were identified in the GWAS of own birth weight but whose effects are mediated through the maternal genome (left) and SNPs that were identified in the GWAS of offspring birth weight but whose effects are mediated through the fetal genome (right). SNPs are aligned to the birth-weight-increasing allele from the GWAS.
inherited by the fetus. Although greater availability of space for fetal growth is a possible explanation, we cannot rule out other causal pathways. For example, causal associations between greater height and a more favorable socio-economic position 34 could enhance maternal nutritional status and result in higher offspring birth weight. We also cannot exclude the contribution of assortative mating 35 to these results: correlation between maternal and paternal height genotypes could lead to similar maternal and fetal Mendelian randomization estimates.
Glycemic traits and birth weight. Maternal glucose is a key determinant of fetal growth: it crosses the placenta, stimulating the production of fetal insulin, which promotes growth 36 . As a consequence, strong positive associations are seen between maternal fasting glucose, fetal insulin levels and offspring birth weight 37 . In a randomized clinical trial of women with gestational diabetes mellitus, glucose control was shown to reduce offspring birth weight 38 . Therefore, we anticipated detecting a positive causal effect of maternal glucose on offspring birth weight, as previously observed using Mendelian randomization in a smaller sample 23 . Indeed, the Mendelian randomization analysis using 33 fasting glucose-associated SNPs (Supplementary Table 14 Table 15 and Fig. 3c) . A large part of the genetic variation underlying fasting glucose levels is implicated in pancreatic β-cell function and thus overlaps with the genetics of insulin secretion. To estimate the causal effect of insulin secretion on birth weight, we used 18 SNPs associated with the disposition index-a measure of insulin's response to glucose, adjusted for insulin sensitivity. Alleles that increase insulin secretion in the mother tend to decrease her glucose levels, which consequently reduces insulin-mediated growth of the fetus. This was reflected in the negative causal estimate from the Mendelian randomization analysis of the effect of the maternal disposition index on offspring birth weight (−0. weight and the traits, and corresponding 95% CIs, were estimated using linkage disequilibrium score regression in LD Hub. Genetic correlations were estimated from the summary statistics of the WLM-adjusted fetal GWAS (WLM-adjusted fetal effect on own birth weight) and WLM-adjusted maternal GWAS (WLM-adjusted maternal effect on offspring birth weight). The total sample size included in the WLM-adjusted GWAS was 406,063 individuals with their own and/or their offspring's birth weight. The genetic correlation estimates are color coded according to their intensity and direction (red, positive correlation; blue, negative correlation). ADHD, attention deficit hyperactivity disorder; HbA1c, hemoglobin A1c; HOMA-B, homeostasis model assessment of β-cell function; HOMA-IR, homeostasis model assessment of insulin resistance. See Supplementary Table 10 for the references for each of the traits and diseases displayed, as well as the genetic correlation results for other traits and diseases. 
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). a, Since maternal and fetal genotypes are correlated, it is essential to account for offspring genotype in this analysis. The continuous, thin arrow represents the relationship between the genetic instrument and intrauterine exposure. The dashed arrows represent potential confounding via maternal characteristics, which, under Mendelian randomization assumptions, are not associated with the genetic instrument. The dotted arrows represent potential violation of Mendelian randomization assumptions via offspring genotype. The thick arrow represents the causal effect of interest. b, Higher offspring birth weight is caused by direct fetal genetic effects of height-raising alleles and indirect effects of maternal height-raising alleles. Indirect maternal effects of height-raising alleles may increase offspring birth weight by increasing the space available for growth, but we cannot rule out alternative explanations; for example, assortative mating. c, Higher maternal fasting glucose levels increase offspring birth weight. Conversely, direct fetal genetic effects of glucose-raising alleles reduce birth weight. This is probably due to their effects on insulin: variants that lower maternal insulin levels increase maternal glucose, which crosses the placenta and stimulates fetal insulin-mediated growth. However, the same variants in the fetus cause lower fetal insulin levels, and consequently, reduced fetal insulin-mediated growth. d, Higher maternal SBP is causally associated with lower offspring birth weight. After adjusting for maternal effects, there was no evidence of an effect of offspring's own SBP genetic score on own birth weight. BW, birth weight; FPG, fasting plasma glucose; SEP, socio-economic position. 1 s.d. of BW = 484 g (refs. 9, 45 ).
per 1 s.d. genetically higher fetal disposition index (Methods), highlighting that genetic variation underlying insulin secretion plays a key role in fetal growth, and suggesting that the genetic effects on the disposition index are similar in fetal and adult life.
Birth weight associations with previously reported GWAS SNPs for fasting glucose, T2D, insulin secretion and insulin sensitivity loci were directionally consistent with the overall genetic correlations, and supported the opposing contributions of fetal versus maternal glucose-raising alleles on birth weight ( Supplementary Figs. 11-14) . Taken together with the WLM-adjusted genetic correlations, the Mendelian randomization results underline the importance of fetal insulin in fetal growth, and show that fetal genetic effects link lower birth weight with reduced insulin secretion and higher T2D risk in later life 6 . However, further work is needed to investigate the role of indirect maternal genetic effects in the relationship between high birth weight and higher future risk of T2D.
Blood pressure and birth weight. Observational studies of the relationship between birth weight and later-life blood pressure have produced mixed findings. Some studies indicate that lower birth weight is associated with higher later-life blood pressure and related comorbidities 39 , whereas others have shown that this relationship could be driven by a statistical artifact due to adjusting for current weight 40, 41 . We have previously shown that genetic factors account for a large proportion of an association between lower birth weight and higher blood pressure 5 , but it was not clear whether this was due to direct fetal genotype effects or indirect maternal effects, or a combination of the two. We explored this association further using several complementary analyses. The estimate of the birth weight-SBP covariance explained was higher when using the maternal genotyped SNP associations with offspring birth weight (65% (95% CI: 57 to 74%)) than when using the fetal genotype associations with own birth weight (56% (95% CI: 48 to 64%); Supplementary Table 17) . A similar pattern was seen with the birth weight-diastolic blood pressure (DBP) covariance (maternal: 72% (95% CI: 58 to 85%); fetal: 56% (95% CI: 46 to 67%); Supplementary Table 17) . Together with the larger maternal than fetal genetic correlation for SBP (Fig. 2) , these results point to the importance of indirect maternal effects of 4 | Mendelian randomization to assess the causal effect of intrauterine growth on offspring adult outcomes, using maternal intrauterine exposures that influence fetal growth. a, Maternal genotype should be associated with offspring birth weight independent of offspring genotype, so it is essential to adjust the analysis for offspring genotype. The continuous, thin arrow represents the relationship between the genetic instrument and intrauterine exposure. The long-dashed arrows denote the (maternal and possibly fetal) genotype associations with birth weight; these arrows highlight the assumption that genetic variation influences offspring adult outcome via intrauterine growth, not birth weight. The short-dashed arrows represent potential confounding via maternal and offspring characteristics. The dotted arrow represents potential violation of assumptions of the Mendelian randomization analysis via offspring genotype. The thick arrow represents the causal effect of interest. We have not estimated the size of the causal effect as we do not have effect estimates for the SNP-maternal intrauterine exposures influencing fetal growth. However, we have used the presence versus absence and direction of association in 3,886 mother-offspring pairs to indicate whether the intrauterine environment causes changes in adult offspring SBP (see Supplementary Table 18 for full results). b, Our results show that the observed negative correlation between birth weight and later SBP may be driven by the causal effect of higher maternal SBP on lower offspring birth weight (red arrow), in combination with the subsequent transmission of SBPassociated alleles to offspring (blue arrow), which then increase offspring SBP. Fig. 3d and Supplementary Tables 14 and 15) . Similar results were seen in the WLM-adjusted Mendelian randomization analyses of DBP on offspring and own birth weight.
Estimating the causal effect of birth weight-lowering intrauterine exposures on offspring SBP. A key question is whether maternal SNPs that reduce offspring birth weight through intrauterine effects are also associated with higher SBP in their adult offspring. Such an association would suggest that the maternal intrauterine effects cause the later SBP effect (that is, through developmental adaptations) ( Fig. 4a and Supplementary Fig. 17 ). To investigate this possibility, we tested the conditional association between maternal and offspring genetic scores for birth weight and offspring SBP, as measured in 3,886 mother-offspring pairs in the UK Biobank, with sensitivity analyses in 1,749 father-offspring pairs. The fetal genetic score for lower birth weight was associated with higher offspring SBP, even after adjustment for maternal (or paternal) birth weight genotypes. However, when adjusted for fetal genotypes, the maternal genetic score for lower birth weight was associated with lower (not higher) offspring SBP (Supplementary Table 18 ). Taken together, our results show that the observed negative correlation between birth weight and later SBP is driven by (1) the causal effect of higher maternal SBP on lower offspring birth weight (Fig. 3d) , in combination with (2) the subsequent transmission of SBP-associated alleles to offspring, which then increase offspring SBP (Fig. 4b) , rather than by long-term developmental responses to adverse in utero conditions.
Discussion
In greatly expanded GWASs and follow-up analyses of own and offspring birth weight, we have identified 129 novel association signals and partitioned the genetic effects on birth weight into direct fetal and indirect maternal (intrauterine) effects. Using these partitioned effects, we identified fetal-and maternal-specific mechanisms and tissues involved in the regulation of birth weight, and mechanisms with directionally opposing effects in the fetus and mother (for example, insulin secretion and fasting glucose). Mendelian randomization analyses using the WLM-adjusted estimates showed that (1) both direct fetal and indirect maternal effects of height-raising genotypes contribute to higher offspring birth weight; (2) fetal (and not maternal) genotype effects explain the negative genetic correlation between birth weight and later T2D; and (3) the negative genetic correlation between birth weight and adult SBP is the result of both indirect SBP-raising effects of maternal genotypes reducing offspring birth weight, and direct effects of fetal genotypes on higher adult SBP. The resolution of maternal versus fetal effects was higher in these Mendelian randomization analyses than has previously been achieved using analyses of available mother-child pairs 23 , due to greater statistical power. Recently, a number of authors have attempted to use Mendelian randomization methodology to investigate causal links between birth weight and later T2D [42] [43] [44] . However, such naive Mendelian randomization analyses using two-sample approaches in unrelated sets of individuals, which do not properly account for the correlation between maternal and fetal genotype effects, may result in erroneous conclusions regarding causality. Future investigations into causal links between birth weight and later T2D or other disease outcomes will require larger samples than are currently available, with maternal and offspring genotypes and offspring later-life disease outcomes.
There are some limitations to this study (see Supplementary Note for a full discussion). First, the Mendelian randomization results concern birth weight variation within the normal range and do not necessarily reflect the effects of extreme environmental events (for example, famine), which may exert qualitatively different effects. Additionally, we have assumed a linear relationship between birth weight and later-life traits, which may be an oversimplification for some traits such as T2D. Second, birth weight is the end marker of a developmental process, with critical periods during the process that may make the fetus particularly sensitive to environmental influences. The Mendelian randomization analyses could therefore be masking effects at certain critical periods. Third, we have assumed that genetic variants identified in large GWASs of SBP and glycemic traits in males and non-pregnant females are similarly associated in pregnant women. Fourth, we have not investigated the potential gender difference in the associations between birth weight and later-life traits. Fifth, we have assumed that the critical period of exposure to indirect maternal genetic effects is pregnancy, and that the estimates do not reflect pre-pregnancy effects on primordial oocytes or postnatal effects 45 . Sixth, we have not considered paternal genotypes, and it is possible that this omission has biased the results of some of our analyses. Finally, although we were able to fit the full SEM at the 209 lead SNPs, we were unable to fit the SEM, including the 2 degrees of freedom test (that is, where maternal and fetal paths are constrained to 0) at all SNPs across the genome.
To conclude, the systematic separation of fetal from maternal genetic effects in a well-powered study has enhanced our understanding of the regulation of birth weight and of its links with later cardio-metabolic health. In particular, we show that the association between lower birth weight and higher adult blood pressure is attributable to genetic effects, and not to intrauterine programming. In successfully separating maternal from fetal genetic effects and using them in Mendelian randomization analyses, this work sets a precedent for future studies seeking to understand the causal role of the intrauterine environment in later-life health.
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GWAS of own birth weight.
European ancestry meta-analysis. The European ancestry GWAS meta-analysis of own birth weight consisted of two components ( Supplementary Fig. 1): (1) 80,745 individuals from 35 studies participating in the EGG Consortium from Europe, the United States and Australia; and (2) 217,397 individuals of white European origin from the UK Biobank (see Supplementary Note for details on phenotype preparation and GWAS analyses). We combined the summary statistics from the EGG meta-analysis with the UK Biobank summary statistics using a fixed-effects meta-analysis in GWAMA 46 (maximum n = 297,142). Variants failing GWAS quality-control filters, reported in <50% of the total sample size in the EGG component, or with MAF < 0.1% were excluded. We also performed a fixed-effects meta-analysis of the association summary statistics for 16,095 directly genotyped SNPs on the X chromosome from the UK Biobank and the EGG meta-analysis using GWAMA 46 (maximum n = 270,929). Genome-wide significance was defined as P < 6.6 × 10
, as calculated by Kemp et al. 47 , which was similar to the thresholds calculated using permutations by Jones et al. 48 . A locus was defined as one or more SNPs reaching genome-wide significance within a region of the genome; two genome-wide-significant SNPs were defined as belonging to two separate loci if the distance between them was ≥500 kb. The lead SNP within each locus was the SNP with the smallest P value.
Several sensitivity analyses were conducted to confirm the quality of our meta-analysis results (see Supplementary Note for details). Univariate linkage disequilibrium score regression 49 estimated the genomic inflation as 1.08, indicating that the majority of genome-wide inflation of the test statistics was due to polygenicity. To assess the impact of this inflation, we recalculated the association P values after adjusting the test statistics for the linkage disequilibrium score regression intercept (Supplementary Table 5 ).
COJO analysis to identify additional independent signals. Approximate COJO analysis 13 was performed in GCTA 50 using the European ancestry meta-analysis summary statistics to identify independent association signals attaining genomewide significance (P < 6.6 × 10
−9
). The linkage disequilibrium reference panel was made up of 344,246 unrelated UK Biobank participants defined by the UK Biobank as having British ancestry, and SNPs were restricted to those present in the Haplotype Reference Consortium (HRC) reference panel. At each locus, only SNPs labeled by GCTA as 'independent' and not in linkage disequilibrium with the original lead SNP (r 2 < 0.05) were listed as secondary SNPs.
Trans-ethnic meta-analysis. To identify any further independent birth-weightassociated SNPs, we conducted a trans-ethnic meta-analysis combining three components ( Supplementary Fig. 1 ): (1) 80,745 individuals from the European ancestry component within the EGG consortium; (2) 12,948 individuals from nine studies within the EGG consortium from diverse ancestry groups: African American, Afro-Caribbean, Mexican, Chinese, Thai, Filipino, Surinamese, Turkish and Moroccan; and (3) 227,530 individuals of all ancestries from the UK Biobank. The same strategy and variant filtering criteria were applied as in the European meta-analysis ( Supplementary Fig. 1 ). Univariate linkage disequilibrium score regression 49 estimated the genomic inflation as 1.08. P values after adjustment of the test statistics for the linkage disequilibrium score regression intercept are presented in Supplementary Table 5 .
GWAS of offspring birth weight.
European ancestry meta-analysis. The European ancestry GWAS meta-analysis of offspring birth weight consisted of three components ( Supplementary Fig. 2 ): (1) 12,319 individuals from 10 GWASs in the EGG consortium of European descent imputed up to the HapMap 2 reference panel; (2) 7,542 individuals from 2 GWASs in the EGG consortium of European descent imputed up to the HRC panel; and (3) 190,406 individuals of white European origin from the UK Biobank (see Supplementary Note for details on phenotype preparation and GWAS analyses). We conducted a European ancestry fixed-effects meta-analysis to combine the association summary statistics from the three components using GWAMA 46 (max n = 210,267). We also performed a fixed-effects meta-analysis of the association summary statistics for 18,137 directly genotyped SNPs on the X chromosome from the UK Biobank and EGG meta-analysis using GWAMA 46 (max n = 197,093). The same strategy and variant filtering criteria were applied as in the meta-analysis of own birth weight, and the same sensitivity analyses were conducted (Supplementary Note).
Univariate linkage disequilibrium score regression 49 estimated the genomic inflation as 1.05. We recalculated the P values after adjusting the test statistics for this linkage disequilibrium score intercept (Supplementary Table 5 ).
Approximate COJO analysis to identify additional independent signals. We performed approximate COJO analysis 13 using the European ancestry metaanalysis summary statistics of offspring birth weight. We used the same reference panel as in the own-birth-weight analysis and listed any secondary 'independent' SNPs associated with offspring birth weight.
Trans-ethnic meta-analysis. We conducted a trans-ethnic meta-analysis combining three components (Supplementary Fig. 2): (1) 12,319 individuals from 10 GWASs in the EGG consortium of European descent imputed up to the HapMap 2 reference panel; (2) 7,542 individuals from 2 GWASs in the EGG consortium of European descent imputed up to the HRC panel; and (3) 210,208 individuals of all ancestries from the UK Biobank. The same strategy and variant filtering criteria were applied as in the European meta-analysis ( Supplementary Fig. 2) , and the same sensitivity analyses were conducted (Supplementary Note). Univariate linkage disequilibrium score regression 49 estimated the genomic inflation as 1.04, and the recalculated P values after adjusting the test statistics for this linkage disequilibrium score intercept are presented in Supplementary Table 5 .
Colocalization methods. For each signal where we identified different lead SNPs in the GWASs of own birth weight and offspring birth weight, we performed colocalization analysis using the 'coloc' R package 51 . For each signal, we input the regression coefficients, their variances, and SNP MAFs for all SNPs 500 kb up-and downstream of the lead SNP from the European meta-analysis. We used the coloc. abf() function, with its default parameters, to calculate posterior probabilities that the own birth weight and offspring birth weight lead SNPs were independent (H 3 ) or shared the same associated variant (H 4 ). We called variants the same signal if the H 4 posterior probability was greater than 0.50, and different signals if the H 3 posterior probability was greater than 0.50.
Estimation of genetic variance explained. First, we estimated the proportion of birth weight variance explained by fetal genotypes, maternal genotypes and the covariance between the two at the 190 genome-wide-significant signals in the Norwegian Mother and Child Cohort Study (MoBa-HARVEST; https://www.fhi. no/en/studies/moba/). This sample was independent of samples contributing to the discovery meta-analyses, apart from a small potential overlap with mothers from the MoBa 2008 sample that was included in the GWAS of offspring birth weight (<0.07% of the meta-analysis sample). For the 19 signals that had different maternal and fetal lead SNPs, the fetal SNP (and not the maternal SNP) was used in the analysis to avoid collinearity in the model. We excluded multiple births, babies of non-European descent, babies born before 37 weeks of gestation, and babies born with a congenital anomaly or still-born. Birth weight was z-score transformed and all models were adjusted for sex, gestational duration and the first four ancestry-informative principal components. We conducted a linear regression analysis in R 52 using 13,934 motheroffspring pairs where offspring birth weight was regressed on the maternal and fetal genotypes at all 190 SNPs simultaneously. The proportion of variance explained by fetal genotypes at the 190 genome-wide-significant signals was calculated as:
Where p i is the effect allele frequency of the ith SNP, β̂f i is the regression coefficient for the effect of the offspring's genotype at the ith SNP on offspring birth weight, and var(BW) is the variance of offspring birth weight (which is approximately 1 as birth weight was z-score transformed). A similar formula was used to calculate the variance explained by maternal genotypes, using:
Where βm i is the regression coefficient for the effect of the maternal genotype at the ith SNP on offspring birth weight. The following formula was used to calculate twice the covariance:
Second, we used maternal GCTA 11 to estimate the proportion of variance in birth weight explained by genome-wide SNPs, or SNPs they tag, in the fetal genome or maternal genome, the covariance between the two and environmental factors in MoBa-HARVEST. The same phenotype was used as in the previous analysis and the model was adjusted for sex and gestational duration. Mothers or offspring were 78 traits are described by Frayling et al. 57 . Association statistics for the 209 lead birth-weight-associated SNPs were then extracted from the results (Supplementary  Table 13 ). Additionally, we searched the NHGRI GWAS (https://www.ebi.ac.uk/ gwas/; accessed 16 January 2018) for the 209 lead birth-weight-associated SNPs, or SNPs in high linkage disequilibrium with the 209 lead SNPs (r 2 > 0.8), and reported associations with other traits (Supplementary Table 13 ).
Linkage disequilibrium score regression. Linkage disequilibrium score regression, which has been described in detail elsewhere 18 , was used to estimate the genetic correlation between birth weight and a range of traits and diseases. We used LD Hub 58 (ldsc.broadinstitute.org/) to perform the linkage disequilibrium score regression analyses. Due to the different linkage disequilibrium structure across ancestry groups, the summary statistics from the European-only birth weight analyses were uploaded to LD Hub, and genetic correlations were calculated with all available phenotypes. We conducted four separate analyses in LD Hub using (1) GWAS meta-analysis of own birth weight; (2) GWAS meta-analysis of offspring birth weight; (3) WLM-adjusted fetal effect; and (4) WLM-adjusted maternal effect.
To calculate the genetic correlation between the maternal and fetal effect estimates from the unadjusted and WLM-adjusted analyses, and also between gestational duration and the WLM-adjusted maternal and fetal effects, we used the scripts provided by the developer (https://github.com/bulik/ldsc).
Mendelian randomization analyses of maternal and fetal exposures on offspring birth weight. Two-sample Mendelian randomization analyses were performed with own or offspring birth weight as outcomes. The exposures included height, fasting glucose, disposition index of insulin secretion 59 , insulin sensitivity, SBP and DBP. The SNP-exposure associations were taken from external studies (Supplementary Table 14 ). The SNP-outcome associations were taken from the current European GWAS meta-analyses of own birth weight, offspring birth weight, WLMadjusted fetal effect and WLM-adjusted maternal effect. Two-sample Mendelian randomization regresses the effect sizes of SNP-outcome associations against the effect sizes of SNP-exposure associations, with an inverse-variance weighted analysis, giving similar results to the two-stage least-squares analysis in a single sample 60 . We performed several sensitivity analyses to assess the impact of genetic pleiotropy on the causal estimates including MR-Egger 61 , Weighted Median 62 and Penalized Weighted Median 62 (see Supplementary Table 15 for results). Details of the R code for the Mendelian randomization analyses are provided elsewhere 61, 62 . Due to the strong negative correlation between estimates of the maternal and fetal genetic effects on birth weight, we conducted simulations to confirm that this correlation did not bias the results of downstream Mendelian randomization analyses; these simulations are described in the Supplementary Note.
Transmitted/non-transmitted allele scores in ALSPAC. Allelic transmission was determined for 4,962 mother-offspring pairs in ALSPAC. First, we converted maternal and fetal genotypes into best-guess genotypes where SNPs of interest had been imputed. Where one or both of the mother-offspring pair were homozygous, allelic transmission was trivial to determine. Where both mother and offspring were heterozygous for the SNP of interest, we used phase imputation generated using SHAPEIT2 (ref. 63 ) to examine the haplotypes in the region of the SNP of interest to determine allelic transmission. Weighted allele scores were generated for maternal non-transmitted, shared (maternal transmitted) and paternally inherited fetal alleles for SBP, DBP, fasting glucose, insulin secretion and insulin sensitivity. Associations were tested between the weighted allele scores and birth weight.
Covariance between birth weight and adult traits explained by genotyped SNPs. The genetic and residual covariance between birth weight and several quantitative/disease phenotypes was calculated in the UK Biobank using REML in BOLT-LMM 64 . We included 215,444 individuals of European ancestry with data on own birth weight and 190,406 with data on offspring birth weight. SNPs with MAF < 1%, evidence of deviation from Hardy-Weinberg equilibrium (P ≤ 1 × 10
) or an overall missing rate > 0.015 were excluded, resulting in 524,307 genotyped SNPs for analysis. We then calculated 96% CIs for the proportion of covariance explained by genotyped variants as gcov/(gcov + rcov) ± 1.96 × gcovSE/ abs(gcov + rcov), where gcov is genetic covariance, rcov is the residual covariance, gcovSE is the standard error for gcov, and abs is the absolute value. Details of the phenotype preparation for the adult traits are provided in the Supplementary Note.
Association between maternal SNPs associated with offspring birth weight and later-life offspring SBP. Using the UK Biobank, we tested whether maternal SNPs associated with offspring birth weight were also associated with offspring SBP in later life. The UK Biobank released kinship information generated in KING 65 , which included kinship coefficients and estimates of the proportion of SNPs with zero identical-by-state (IBS0). We defined parent-offspring pairs using the kinship coefficient and IBS0 cut-offs recommended by Manichaikul et al. 65 . There were 5,635 unique parent-offspring pairs of European ancestry with SBP data (for parents who had multiple offspring with SBP data, only the oldest offspring was included in the analysis); 3,886 mother-offspring pairs and 1,749 father-offspring pairs. We tested the relationship between unweighted allelic scores of birth-weight-associated SNPs in mothers/fathers and offspring SBP (see Supplementary Note for SBP phenotype preparation) before and after adjusting for offspring genotypes at the same loci. We examined unweighted allelic scores consisting of all autosomal lead birth-weight-associated SNPs available in the UK Biobank (205 SNPs), 72 autosomal SNPs that showed evidence of a maternal effect and 31 autosomal SNPs that showed evidence only of maternal effects on birth weight. We also looked at the SNPs previously associated with SBP (Supplementary Table 14) as a sensitivity analysis to rule out the possibility of postnatal pleiotropic effects contaminating our results. All analyses were adjusted for offspring age at SBP measurement, sex and assessment center.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The genotype and phenotype data are available on application from the UK Biobank (http://www.ukbiobank.ac.uk/). Individual cohorts participating in the EGG Consortium should be contacted directly as each cohort has different data access policies. GWAS summary statistics from this study are available via the EGG website (https://egg-consortium.org/). The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code
Data collection
Data collection was performed centrally by the UK Biobank and by the investigators of each contributing EGG Consortium study. We provide detailed supplementary tables with characteristics of each study and references to study descriptions.
Data analysis
We used BOLT-LMM (version 2. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. All studies must disclose on these points even when the disclosure is negative.
Sample size
Full descriptions of how we defined the samples included in the GWAS of own or offspring birth weight are included in the methods section. Briefly, we aimed to bring together the largest possible sample size with birth weight and/or offspring birth weight and GWAS data to study the role of genetic variation in birth weight. We excluded some individuals, as described below, and the final sample size was then the number of individuals included in any given statistical test that had no missing data for all genotype and phenotype variables included in the model. These numbers are given clearly in the main body of the article and the Methods section. Our sample size was adequate to recover the 65 known birth weight associated regions and identify 129 novel independent association signals. Additionally, as mentioned in the results section, asymptotic power calculations showed that with our sample size we had 80% power to detect fetal (maternal) effects that explained 0.006% (0.008%) of the variance in birth weight (α=0.05).
Data exclusions Established protocols were used to conduct rigorous data quality control for each study prior to the GWAS analyses.
The following exclusions were made for the birth weight phenotype: i) twins and other multiple births, ii) individuals born before 37 weeks of gestation (where gestational duration was available), iii) any extreme outliers in the birth weight distribution, iv) babies born with congenital anomalies (where available). In the UK Biobank, where there was no gestational duration information, we included only individuals born between 2.5 and 4.5kg. Within each genotyped dataset, to guard against population stratification, principal components analysis was used to exclude ancestry outliers (for example, the European component of the UK Biobank was defined using k-means cluster analysis, described in the Methods section).
In the EGG studies, SNPs were excluded if the INFO<0.4, minimac r2<0.3 or minor allele count was <3. In the UK Biobank, SNPs were excluded if the INFO<0.3, minor allele frequency was <0.1% or they were not HRC imputed SNPs. Additional data exclusions for individual studies are provided in Supplementary Tables 1-4 .
Replication
To determine the overall evidence of association at each SNP, we performed a meta-analysis of available GWAS studies. We checked for evidence of heterogeneity between the European component of the UK Biobank and the EGG European component to verify that there was consistency between the major components of the meta-analysis. This is described in the manuscript.
Randomization Individuals in the UK Biobank were not assigned to specific groups, but data and samples were collected at different study centres and were genotyped in batches and on different arrays. Strict quality control performed centrally by UK Biobank ensured that batch-effects were controlled for in the genotype data. We adjusted genetic association tests for both study centre and data release (see Methods section for detail). We performed Mendelian randomization analyses, based on the assumption that genotype is randomly assigned at conception and thus that the maternal genotype can be used as an unconfounded proxy for a maternal characteristic, such as glucose, height etc. Essentially, using this method (with appropriate control for fetal genotype), birth weight is assessed in individuals effectively randomized to different maternal glucose/height etc levels. The Methods are described in detail in the manuscript.
Blinding
Data collected by both UK Biobank and EGG studies were observational and had no specific interventions. As such, no blinding was required.
Reporting for specific materials, systems and methods
